Patent ID: 11905535
Assignee: EMPYREAN NEUROSCIENCE, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A genetically modified Basidiomycota fungus, comprising an expressed exogenous PsiD gene or an expressed exogenous PsiH gene, or both, and wherein the genetically modified Basidiomycota fungus produces an increased production of a compound selected from the group consisting of:, , and any combination thereof, as compared to production of the same compound(s) in a comparable control Basidiomycota fungus without the expressed exogenous PsiD gene or the expressed exogenous PsiH gene, or both, and wherein
the genetically modified Basidiomycota fungus comprises at least 200% more psilocybin measured by dry weight of the genetically modified Basidiomycota fungus compared to an amount of psilocybin in a comparable control Basidiomycota fungus without the expressed exogenous PsiD gene or the expressed exogenous PsiH gene, or both.